SCHEMBL31361482

SCHEMBL31361482

CC(C)(C)OC(=O)N1CCN(c2ccc(C(=O)Nc3nc(-c4ccccn4)cs3)cc2)CC1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA3 P0DMS8 9/20 0.59
▸ KDM4A O75164 2/20 0.59
▸ KDM4B O94953 2/20 0.59
▸ KDM5B Q9UGL1 2/20 0.59
▸ GRM1 Q13255 1/20 0.56
▸ KDM4E B2RXH2 2/20 0.56
▸ MAPT P10636 2/20 0.56
▸ MEN1 O00255 1/20 0.56
▸ ALDH1A1 P00352 1/20 0.56
▸ HTT P42858 1/20 0.56
▸ KMT2A Q03164 1/20 0.56
▸ NPC1 O15118 2/20 0.54
▸ MAPK1 P28482 2/20 0.54
▸ USP2 O75604 1/20 0.54
▸ ALOX15 P16050 1/20 0.54
▸ KDM5C P41229 1/20 0.54
▸ L3MBTL1 Q9Y468 4/20 0.53
▸ RAB9A P51151 1/20 0.51
▸ MITF O75030 1/20 0.51
▸ NCOA1 Q15788 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31361480 0.91 ADORA3 (0.61) ADORA3KDM4AKDM4BKDM5BGRM1
SCHEMBL18094474 0.86 SMN1; SMN2 (0.49) KDM4EMAPTMEN1ALDH1A1HTT
SCHEMBL24107586 0.85 SMN1; SMN2 (0.51) KDM4EMAPTMEN1HTTKMT2A
SCHEMBL24107632 0.82 ADORA3 (0.69) ADORA3KDM4AKDM4BKDM5BGRM1
SCHEMBL4419709 0.80 TXK (0.47) KDM4EMAPTMEN1ALDH1A1HTT
SCHEMBL2355543 0.79 LRRK2 (0.67) KDM4EMAPTMEN1ALDH1A1HTT
SCHEMBL31361531 0.79 ADORA3 (0.67) ADORA3KDM4AKDM4BKDM5BGRM1
SCHEMBL4419707 0.78 HDAC8 (0.49) KDM4EMAPTMEN1ALDH1A1HTT
SCHEMBL21274054 0.78 MAPT (0.55) MAPTMEN1ALDH1A1KMT2A
SCHEMBL31361538 0.77 ADORA3 (0.64) ADORA3KDM4AKDM4BKDM5BGRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4746882-A1 INHIBITORS OF SMNDC1 AND THEIR THERAPEUTIC USE CeMM - Forschungszentrum für Molekulare Medizin GmbH (AT) 2026-05-27 — — EP disclosed
WO-2025017207-A1 INHIBITORS OF SMNDC1 AND THEIR THERAPEUTIC USE CEMM - FORSCHUNGSZENTRUM FÜR MOLEKULARE MEDIZIN GMBH (AT) 2025-01-23 — — WO disclosed
Send feedback